References
- Kao HJ, Chen WH, Liu JS. Rapid progression of parkinsonism associated with an increase of blood manganese. The Kaohsiung Journal of Medical Sciences 1999; 15: 297–301
- Chen WH, Lan MY, Chang YY, Chen SS, Liu JS. The prevalence of protein C, protein S, and antithrombin III deficiency in non-APS/SLE Chinese adults with noncardiac cerebral ischemia. Clinical and Applied Thrombosis-Hemostasis 2003; 9: 155–162
- Chen WH. Anti-beta2-Glycoprotein I antibody and hypertension in cerebral ischemia. Clinical and Applied Thrombosis-Hemostasis 2004; 10: 55–60
- Chen WH, Chiang TJ, Hsu MC, Liu JS. The validity of eye blink rate in Chinese adults for the diagnosis of Parkinson's disease. Clinical Neurology and Neurosurgery 2003; 105: 90–92
- Straussberg R, Shahar E, Gat R, Brand N. Delayed parkinsonism associated with hypotension in a child undergoing open-heart surgery. Developmental Medicine and Child Neurology 1993; 35: 1011–1014
- Jaskolski D, Zawirski M, Niewodniczy A. Parkinsonism after clipping of bilateral aneurysms of the middle cerebral arteries. Zentralblatt Fur Neurochirurgie 1989; 50: 193–195
- Berger JR, Ross DB. Reversible Parkinson syndrome complicating postoperative hypoparathyroidism. Neurology 1981; 31: 881–882
- Chen WH. An unusual transitory increase of lupus anticoagulant in dengue virus infection complicated with cerebral ischemia. Journal of Infection 2006; 52: e87–91
- Chen WH, Liu JS. Chondrosarcoma, lupus anticoagulant and cerebral ischemia. Journal of Clinical Neuroscience 2005; 12: 305–307
- Chen WH, Lui CC, Chen SS, Liu JS. An increase of blood anti-beta(2)-glycoprotein I antibody associates with cerebral hemorrhage in patients without antiphospholipid antibody syndrome. International Journal of Angiology 2003; 12: 178–182
- Chen WH, Kao YF, Lan MY, Chang YY, Chen SS, Liu JS. The increase of blood anticardiolipin antibody depends on the underlying etiology in cerebral ischemia. Clinical and Applied Thrombosis-Hemostasis 2006; 12: 69–76
- Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce de Leon S. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353–365
- McIntyre JA, Wagenknecht DR. Antiphospholipid antibodies and renal transplantation: A risk assessment. Lupus 2003; 12: 555–559
- Kreikemeier J, Tobias JD. Antiphospholipid antibody syndrome manifested as a postoperative cerebrovascular event in a child. Southern Medical Journal 2000; 93: 1115–1119
- Milanov I, Bogdanova D. Antiphospholipid syndrome and dystonia-parkinsonism. A case report. Parkinsonism & Related Disorders 2001; 7: 139–141
- Milanov IG, Rashkov R, Baleva M, Georgiev D. Antiphospholipid syndrome and parkinsonism. Clinical and Experimental Rheumatology 1998; 16: 623–624
- Kalashnikova LA. Non-ischemic neurological manifestations in patients with primary antiphospholipid syndrome [Rus]. Zhurnal Nevrologii i Psikhiatrii Imeni S S Korsakova 2005; 105: 18–23
- Caronti B, Pittoni V, Palladini G, Valesini G. Anti-beta2-glycoprotein I antibodies bind to central nervous system. Journal of the Neurological Sciences 1998; 156: 211–219
- Dunoyer-Geindre S, de Moerloose P, Galve-de Rochemonteix B, Reber G, Kruithof EK. NFkappa-B is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies. Thrombosis and Haemostasis 2002; 88: 851–857
- Liou HH, Wang CR, Chou HC, Arvanov VL, Chen RC, Chang YC, Chuang CY, Chen CY, Tsai MC. Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons. Life Science 1994; 54: 1119–1125
- Riccio A, Andreassi C, Eboli ML. Antiphospholipid antibodies bind to rat cerebellar granule cells: The role of N-methyl-D-aspartate receptors. Neuroscience Letters 1998; 257: 116–118